S P McKenna

Summary

Affiliation: Galen Research
Country: UK

Publications

  1. ncbi International development of the Parents' Index of Quality of Life in Atopic Dermatitis (PIQoL-AD)
    Stephen P McKenna
    Galen Research, Manchester, UK
    Qual Life Res 14:231-41. 2005
  2. ncbi Measuring the psychosocial consequences of screening
    John Brodersen
    Department and Research Unit of General Practice, University of Copenhagen, Oester Farimagsgade 5, 24Q, Postbox 2099, DK 1014 Copenhagen, Denmark
    Health Qual Life Outcomes 5:3. 2007
  3. ncbi Development and psychometric assessment of the COPD and Asthma Sleep Impact Scale (CASIS)
    Robin F Pokrzywinski
    United BioSource Corporation, Bethesda, MD, USA
    Health Qual Life Outcomes 7:98. 2009
  4. ncbi Translation and validation of non-English versions of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire
    Lynda C Doward
    Galen Research, Manchester, UK
    Health Qual Life Outcomes 5:7. 2007
  5. ncbi Synchrony of change in depressive symptoms, health status, and quality of life in persons with clinical depression
    Paula H Diehr
    Department of Biostatistics F 670 HSB, Box 357232, University of Washington, Seattle, WA 98195 7232, USA
    Health Qual Life Outcomes 4:27. 2006
  6. ncbi Interpreting scores on multiple sclerosis-specific patient reported outcome measures (the PRIMUS and U-FIS)
    James Twiss
    Galen Research Ltd, Manchester, UK
    Health Qual Life Outcomes 8:117. 2010
  7. ncbi Retraction: psychometric characteristics of the ankylosing spondylitis quality of life questionnaire, short form 36 health survey, and functional assessment of chronic illness therapy-fatigue subscale
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, USA
    Health Qual Life Outcomes 7:34. 2009
  8. ncbi Integrating patient-reported outcomes
    Stephen P McKenna
    Galen Research, Manchester, UK
    Value Health 7:S9-12. 2004
  9. ncbi Development and validation of a preference based measure derived from the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for use in cost utility analyses
    Stephen P McKenna
    Galen Research Ltd, Enterprise House, Manchester Science Park, Lloyd Street North, Manchester, M15 6SE, UK
    Health Qual Life Outcomes 6:65. 2008
  10. ncbi Quality of life of children with atopic dermatitis and their families
    Stephen P McKenna
    School of Psychology, University of Central Lancashire, Preston, UK
    Curr Opin Allergy Clin Immunol 8:228-31. 2008

Detail Information

Publications58

  1. ncbi International development of the Parents' Index of Quality of Life in Atopic Dermatitis (PIQoL-AD)
    Stephen P McKenna
    Galen Research, Manchester, UK
    Qual Life Res 14:231-41. 2005
    ..The international development of the Parents' Index of Quality of Life in Atopic Dermatitis (PIQoL-AD), a quality of life (QoL) instrument specific to parents of children with atopic dermatitis (AD) is described...
  2. ncbi Measuring the psychosocial consequences of screening
    John Brodersen
    Department and Research Unit of General Practice, University of Copenhagen, Oester Farimagsgade 5, 24Q, Postbox 2099, DK 1014 Copenhagen, Denmark
    Health Qual Life Outcomes 5:3. 2007
    ..In particular it is important to establish unidimensionality, additivity and item ordering through the application of Item Response Theory...
  3. ncbi Development and psychometric assessment of the COPD and Asthma Sleep Impact Scale (CASIS)
    Robin F Pokrzywinski
    United BioSource Corporation, Bethesda, MD, USA
    Health Qual Life Outcomes 7:98. 2009
    ..We developed and evaluated the psychometric performance of a patient-reported measure to assess the impact on sleep due to respiratory disease, the COPD and Asthma Sleep Impact Scale (CASIS)...
  4. ncbi Translation and validation of non-English versions of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire
    Lynda C Doward
    Galen Research, Manchester, UK
    Health Qual Life Outcomes 5:7. 2007
    ..The Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire is a unidimensional, disease-specific measure developed in the UK and the Netherlands. This study describes its adaptation into other languages...
  5. ncbi Synchrony of change in depressive symptoms, health status, and quality of life in persons with clinical depression
    Paula H Diehr
    Department of Biostatistics F 670 HSB, Box 357232, University of Washington, Seattle, WA 98195 7232, USA
    Health Qual Life Outcomes 4:27. 2006
    ..We followed 982 clinically depressed persons to determine which measures changed and whether the change was synchronous with change in depressive symptoms...
  6. ncbi Interpreting scores on multiple sclerosis-specific patient reported outcome measures (the PRIMUS and U-FIS)
    James Twiss
    Galen Research Ltd, Manchester, UK
    Health Qual Life Outcomes 8:117. 2010
    ....
  7. ncbi Retraction: psychometric characteristics of the ankylosing spondylitis quality of life questionnaire, short form 36 health survey, and functional assessment of chronic illness therapy-fatigue subscale
    Dennis A Revicki
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, USA
    Health Qual Life Outcomes 7:34. 2009
    ..Health and Quality of Life Outcomes 2009, 7: 6...
  8. ncbi Integrating patient-reported outcomes
    Stephen P McKenna
    Galen Research, Manchester, UK
    Value Health 7:S9-12. 2004
    ..The new model is illustrated by data collected using different types of outcome measures. Finally, the different outcomes are related to their purpose in clinical studies...
  9. ncbi Development and validation of a preference based measure derived from the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for use in cost utility analyses
    Stephen P McKenna
    Galen Research Ltd, Enterprise House, Manchester Science Park, Lloyd Street North, Manchester, M15 6SE, UK
    Health Qual Life Outcomes 6:65. 2008
    ..The purpose of this study was to develop and validate a preference based measure from the CAMPHOR that could be used in cost-utility analyses...
  10. ncbi Quality of life of children with atopic dermatitis and their families
    Stephen P McKenna
    School of Psychology, University of Central Lancashire, Preston, UK
    Curr Opin Allergy Clin Immunol 8:228-31. 2008
    ..This review looks at these developments and reports on recently published articles on the impact of the condition on affected children and other members of their family...
  11. ncbi Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life
    S P McKenna
    Galen Research, Manchester, UK
    J Eur Acad Dermatol Venereol 20:248-54. 2006
    ..To report on quality of life (QoL) and health-related quality of life (HRQL) impacts of pimecrolimus (Elidel, Novartis A.G., Basel, Switzerland, SDZ ASM 981) 1% cream in the long-term treatment of paediatric atopic dermatitis...
  12. ncbi The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension
    S P McKenna
    Galen Research, Enterprise House, Manchester Science Park, Lloyd Street North, Manchester M15 6SE, UK
    Qual Life Res 15:103-15. 2006
    ..The aim of the study was to develop health-related quality of life (symptoms and functioning) scales and a quality of life scale that would allow comprehensive, accurate and valid patient-reported outcome assessment in clinical studies...
  13. ncbi Development of the US PSORIQoL: a psoriasis-specific measure of quality of life
    Stephen P McKenna
    Galen Research, Enterprise House, Manchester Science Park, Manchester, UK
    Int J Dermatol 44:462-9. 2005
    ..The aim of the current study was to produce and validate a conceptually equivalent US version of the PSORIQoL with equally good psychometric properties...
  14. ncbi Quality of life in infants and children with atopic dermatitis: addressing issues of differential item functioning across countries in multinational clinical trials
    Stephen P McKenna
    Department of Psychology, University of Central Lancashire, Preston, UK
    Health Qual Life Outcomes 5:45. 2007
    ..From these it was intended to develop two separate scales, one assessing impact on carers and the other determining the effect on the child...
  15. ncbi International development of the patient-reported outcome indices for multiple sclerosis (PRIMUS)
    Stephen P McKenna
    Galen Research, Manchester, UK
    Value Health 13:946-51. 2010
    ..This study describes the adaptation of eight language versions for Canadian English, Canadian French, French, German, Italian, Spanish, Swedish, and US English...
  16. ncbi Adaptation of the QoL-AGHDA scale for adults with growth hormone deficiency in four Slavic languages
    Stephen P McKenna
    Galen Research Ltd, Manchester, UK
    Health Qual Life Outcomes 9:60. 2011
    ..The present study describes the adaptation of the QoL-AGHDA for use in the following four Slavic languages; Czech, Polish, Serbian and Slovakian...
  17. ncbi Measuring patient-reported outcomes: moving beyond misplaced common sense to hard science
    Stephen P McKenna
    Galen Research Ltd, Enterprise House, Manchester Science Park, Lloyd Street North, Manchester M15 6SE, UK
    BMC Med 9:86. 2011
    ..The present article questions these orthodox views and suggests alternative approaches that have been shown to be effective...
  18. ncbi Development and validation of the living with chronic obstructive pulmonary disease questionnaire
    Stephen P McKenna
    Galen Research, Manchester, UK
    Qual Life Res 20:1043-52. 2011
    ..The purpose of the study was to develop a patient-based PRO measure for COPD that captures the overall everyday impact of living with COPD from the patient's perspective...
  19. ncbi Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials
    S P McKenna
    Galen Research, Enterprise House, Lloyd Street North, Manchester M15 6SE, UK
    Br J Dermatol 149:323-31. 2003
    ..Several patient-completed instruments are available to measure outcome in dermatological conditions but these primarily focus on severity of disease rather than on QoL...
  20. ncbi Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis
    S P McKenna
    Galen Research, Manchester, UK
    Ann Rheum Dis 63:162-9. 2004
    ..Patient reported outcome measures used in studies of psoriatic arthritis (PsA) have been found to be inadequate for determining the impact of the disease from the patient's perspective...
  21. ncbi The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus
    L C Doward
    Galen Research, Enterprise House, Manchester Science Park, Lloyd Street North, Manchester M15 6SE, UK
    Ann Rheum Dis 68:196-200. 2009
    ..This paper describes the development and testing of a new instrument to measure QoL in systemic lupus erythematosus (L-QoL)...
  22. ncbi International development of the Quality of Life in Depression Scale (QLDS)
    S P McKenna
    Galen Research, Manchester Science Park, Enterprise House, Lloyd Street North, Manchester M15 6SE, UK
    J Affect Disord 63:189-99. 2001
    ..This paper describes the production and psychometric assessment of nine new language versions for Canada (French and English), Denmark, France, Germany, Italy, Morocco, Spain and the US...
  23. ncbi The responsiveness and validity of the CAMPHOR Utility Index
    D M Meads
    Galen Research, Enterprise House, Manchester Science Park, Manchester, M15 6SE, UK
    Eur Respir J 32:1513-9. 2008
    ..The CAMPHOR Utility Index is valid and responsive to change. Patients can experience significant and important improvements even if they do not improve on the basis of traditional outcomes, such as NYHA functional class...
  24. ncbi A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD)
    D Whalley
    Galen Research, Enterprise House, Lloyd Street North, Manchester M15 6SE, UK
    Br J Dermatol 150:274-83. 2004
    ..CONCLUSIONS: The QoLIAD is a practical, reliable, valid and culturally applicable instrument for measuring the impact of AD and its treatment on QoL in clinical trials or in routine clinical practice...
  25. ncbi Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis
    L C Doward
    Galen Research, Enterprise House, Manchester Science Park, Lloyd Street North, Manchester M15 6SE, UK
    Ann Rheum Dis 62:20-6. 2003
    ..Although disease-specific health status measures are available for ankylosing spondylitis (AS), no instrument exists for assessing quality of life (QoL) in the condition...
  26. ncbi The development and validation of the Unidimensional Fatigue Impact Scale (U-FIS)
    D M Meads
    Galen Research, Manchester, United Kingdom
    Mult Scler 15:1228-38. 2009
    ..The multidimensional assessment of fatigue is complicated by the interrelation of its multiple causes and effects...
  27. ncbi Further validation and responsiveness assessment of the Herpes Outbreak Impact Questionnaire and Herpes Symptom Checklist
    David M Meads
    Galen Research, Enterprise House, Manchester Science Park, Lloyd Street North Manchester, UK
    Value Health 12:397-400. 2009
    ..This report describes the validation of paper-and-pencil versions of the scales and responsiveness assessments in an Australian clinical trial...
  28. ncbi The development of patient-reported outcome indices for multiple sclerosis (PRIMUS)
    L C Doward
    Galen Research Ltd, Manchester, UK
    Mult Scler 15:1092-102. 2009
    ..Complex diseases such as multiple sclerosis (MS) present dilemmas over the choice of patient-reported outcome measures as no single scale can inform on all types of MS impact from the patient's perspective...
  29. ncbi The quality of life of parents of children with atopic dermatitis: interpretation of PIQoL-AD scores
    D M Meads
    Galen Research, Enterprise House, Manchester, UK
    Qual Life Res 14:2235-45. 2005
    ..It is argued that it would be useful for clinicians to gain an understanding of the meaning of QoL scores through routine use of such measures in clinical practice...
  30. ncbi The development of the Herpes Symptom Checklist and the Herpes Outbreak Impact Questionnaire
    Lynda C Doward
    Galen Research, Manchester, UK
    Value Health 12:139-45. 2009
    ..The Herpes Outbreak Impact Questionnaire (HOIQ) and the Herpes Symptom Checklist (HSC) were designed to be acceptable to clinical professionals and to reflect patients' experience...
  31. ncbi Effectiveness of needs-based quality of life instruments
    Lynda C Doward
    Galen Research, Manchester, UK
    Value Health 7:S35-8. 2004
    ....
  32. ncbi International development of the Unidimensional Fatigue Impact Scale (U-FIS)
    Lynda C Doward
    Galen Research, Manchester, UK
    Value Health 13:463-8. 2010
    ..The objective is to produce eight new language versions of the U-FIS: Canadian-English, Canadian-French, French, German, Italian, Spanish, Swedish, and US-English...
  33. ncbi The benefit of pimecrolimus (Elidel, SDZ ASM 981) on parents' quality of life in the treatment of pediatric atopic dermatitis
    Diane Whalley
    Galen Research, Manchester, United Kingdom Novartis Pharma AG, Basel, Switzerland
    Pediatrics 110:1133-6. 2002
    ..A secondary aim of both trials, and the focus of this article, was to evaluate the quality-of-life (QoL) impact of pimecrolimus compared with its vehicle...
  34. ncbi Dermatological applications of needs-based quality of life instruments
    David M Meads
    Galen Research, Manchester, UK
    Value Health 7:S31-4. 2004
    ..Needs-based instruments have been developed for a wide range of diseases. Recently, they have been applied widely in dermatology. This paper describes these applications and shows how they have proved of value...
  35. ncbi Defining patient-reported outcomes
    Lynda C Doward
    Galen Research, Manchester, UK
    Value Health 7:S4-8. 2004
    ..Needs-based QoL is defined and it is argued that this approach (the extent to which an individual is able to meet his or her needs) provides a good working indicator of QoL...
  36. ncbi Development of needs-based quality of life instruments
    Stephen P McKenna
    Galen Research, Manchester, UK
    Value Health 7:S17-21. 2004
    ....
  37. ncbi Adapting the Asthma Life Impact Scale (ALIS) for use in Southern European (Italian) and Eastern European (Russian) cultures
    J Twiss
    Galen Research Ltd, Manchester, UK
    J Med Econ 14:729-38. 2011
    ..It was developed in the UK and US and has proven to be acceptable to patients, to have good psychometric properties, and to be unidimensional...
  38. ncbi The patient-reported impact of scars measure: development and validation
    Benjamin C Brown
    Plastic and Reconstructive Surgery Research, Manchester Interdisciplinary Biocenter, The University of Manchester, Manchester, UK
    Plast Reconstr Surg 125:1439-49. 2010
    ..Quantification with disease-specific patient-reported outcome measures is essential for assessing disease severity. This study aimed to develop and validate the first scar-specific patient-reported outcome measure...
  39. ncbi Impact of lipoatrophy on patient-reported outcomes in antiretroviral-experienced patients
    Lynda C Doward
    Galen Research Ltd, Manchester, United Kingdom
    AIDS Read 18:242-6, 252-6, 262-4. 2008
    ..However, the patient-reported outcome measures used in clinical studies were not lipoatrophy-specific and had limited ability to show real changes in health status associated with lipoatrophy...
  40. ncbi Development and validation of the Asthma Life Impact Scale (ALIS)
    David M Meads
    Galen Research Ltd, Manchester, United Kingdom
    Respir Med 104:633-43. 2010
    ..Current asthma patient-reported outcome (PRO) measures focus on symptoms and functioning and may not capture the holistic impact of asthma on the quality of life of the patient...
  41. ncbi The translation and cultural adaptation of patient-reported outcome measures
    Stephen P McKenna
    Value Health 8:89-91. 2005
  42. ncbi Health status measurement in Parkinson's disease: validity of the PDQ-39 and Nottingham Health Profile
    Peter Hagell
    Section of Restorative Neurology, Department of Clinical Neuroscience, University Hospital, Lund, Sweden
    Mov Disord 18:773-83. 2003
    ..Although promising, both questionnaires warrant further developmental work and stronger support of measurement validity before they could be considered fully suitable for valid use in PD, in particular in earlier stages of the disease...
  43. ncbi Development and psychometric analysis of the Japanese version of the Nottingham Health Profile: cross-cultural adaptation
    Koichi Nishimura
    Respiratory Division, Kyoto-Katsura Hospital, Kyoto
    Intern Med 43:35-41. 2004
    ..Different sections of the Japanese NHP were shown to have known group validity...
  44. ncbi The needs-based approach to quality of life assessment
    Stephen P McKenna
    Value Health 7:S1-3. 2004
  45. ncbi Functional disability and quality of life in patients with ankylosing spondylitis
    Stephen P McKenna
    Rheumatol Int 24:57-8; author reply 59-60. 2004
  46. ncbi The psychometric properties of the psoriasis disability index in United States patients
    Tamar Nijsten
    Department of Dermatology, University Hospital Antwerp, Antwerp, Belgium
    J Invest Dermatol 125:665-72. 2005
    ..The psychometric properties of instruments designed to measure the impact of psoriasis should be tested in populations in which the instrument is to be applied...
  47. ncbi Adaptation of the rheumatoid arthritis quality of life scale for Estonia
    Marika Tammaru
    Department of Internal Medicine, Faculty of Medicine, University of Tartu, Puusepa 6, Tartu 51014, Estonia
    Rheumatol Int 26:655-62. 2006
    ..Predicted convergent and divergent validity was demonstrated. Unidimensionality of the instrument was confirmed by excellent fit to the Rasch model. The RAQoL is appropriate for use in clinical studies and trials involving RA patients...
  48. ncbi United States validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR)
    Mardi Gomberg-Maitland
    University of Chicago Medical Center, Chicago, Illinois 60637, USA
    J Heart Lung Transplant 27:124-30. 2008
    ..To enable use in the United States, this study adapted, field-tested, and evaluated its reliability and validity at a single center in Chicago...
  49. ncbi Evaluation of the psychometric properties of the Hungarian quality of life in depression scale
    Reka Viola
    University of Szeged, Faculty of Pharmacy, Department of Clinical Pharmacy, Szikra u 8, 6725 Szeged, Hungary
    Eur Psychiatry 23:49-52. 2008
    ..The new language version was shown to be well-accepted by respondents and to have excellent psychometric properties...
  50. ncbi Adaptation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) into French-Canadian and English-Canadian
    Donna Coffin
    Actelion Pharmaceuticals Canada Inc, Laval, Canada
    Can Respir J 15:77-83. 2008
    ..The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) is the first disease-specific instrument for assessing patient-reported symptoms, functioning and quality of life (QoL) in pulmonary arterial hypertension (PAH)...
  51. ncbi Adapting quality of life instruments
    Angelo Swaine-Verdier
    Freelance translator, Chevalet, Mazerat-Aurouze, France
    Value Health 7:S27-30. 2004
    ....
  52. ncbi Application of Rasch analysis in the development and application of quality of life instruments
    Alan Tennant
    Academic Unit of Musculoskeletal and Rehabilitation Medicine, University of Leeds, Leeds, UK
    Value Health 7:S22-6. 2004
    ..By ensuring that scales are based on the same measurement model and that they fit the Rasch model it is possible for QoL scores to be compared across diseases by means of cocalibration and item banking...
  53. ncbi Development and validation of a needs-based quality of life instrument for osteoarthritis
    Anne Maree Keenan
    University of Leeds, Chapel Allerton Hospital, Leeds, UK
    Arthritis Rheum 59:841-8. 2008
    ..To develop and validate a disease-specific quality of life (QOL) measure for osteoarthritis (OA), the OAQoL, using the needs-based conceptual model...
  54. ncbi International use of health status questionnaires in Parkinson's disease: translation is not enough
    Peter Hagell
    Department of Nursing, Lund University, P O Box 157, SE 221 00 Lund, Sweden
    Parkinsonism Relat Disord 10:89-92. 2003
    ..This preliminary study illustrates the need for documented linguistic validity before new language adaptations of patient-reported outcome measures can be considered suitable for use in clinical trials, research, and practice...
  55. ncbi Assessing the quality of life of patients in phases I and II anti-cancer drug trials: interviews versus questionnaires by Cox K
    Stephen P McKenna
    Soc Sci Med 58:659-60; author reply 661. 2004
  56. ncbi Change in generic and disease-specific health-related quality of life during a one-year period in patients with newly detected chronic obstructive pulmonary disease
    Mitsuhiro Tsukino
    Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Respiration 69:513-20. 2002
    ....
  57. ncbi Dimensionality of the dermatology life quality index (DLQI): a commentary
    Tamar Nijsten
    Acta Derm Venereol 86:284-5; author reply 285-6. 2006